Delivery Order SPE2DR25D3013-SPE2DR26F6S3V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units) with a ceiling value of $1,659.37. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injectors with a firm fixed price of $12,222.69 and completion deadline of September 23, 2025. This non-competitive delivery order represents a single-unit transaction executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $3,431.63 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, issued on a non-competitive, non-set-aside basis, represents a single transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a $2,504.70 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was executed without a set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $8,203.07 under a firm fixed price arrangement. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,364.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on June 2, 2025. This firm fixed-price delivery order, which is scheduled for completion by June 3, 2025, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger pharmaceutical supply contract vehicle with the DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.18 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL units). This competitively awarded, firm fixed-price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,480.68 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on August 27, 2025. This firm fixed price, competitively awarded delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28,...
- The Defense Logistics Agency awarded a $18,566.54 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6S3VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded on a competitive basis. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical vendor for federal medical supply needs through its extensive contract portfolio with the Defense Logistics Agency. The company's DLA IDC enables the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This specific order for Zepbound, a GLP-1 receptor agonist medication used in diabetes and weight management treatment, exemplifies the diversity of pharmaceutical commodities AmerisourceBergen delivers to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/14/25 |